Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial.

Janjigian YY, Oh DY, Pelster M, Wainberg ZA, Prusty S, Nelson S, DuPage A, Thompson A, Koralek DO, Sison EAR, Rha SY

DOI: 10.1038/s41591-025-04022-w
Published: 2025 Dec
Container: Nature medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-04022-w,
  title = {Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial.},
  author = {Janjigian YY and Oh DY and Pelster M and Wainberg ZA and Prusty S and Nelson S and DuPage A and Thompson A and Koralek DO and Sison EAR and Rha SY},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-025-04022-w},
  url = {https://doi.org/10.1038/s41591-025-04022-w}
}

RIS

TY  - JOUR
TI  - Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial.
AU  - Janjigian YY
AU  - Oh DY
AU  - Pelster M
AU  - Wainberg ZA
AU  - Prusty S
AU  - Nelson S
AU  - DuPage A
AU  - Thompson A
AU  - Koralek DO
AU  - Sison EAR
AU  - Rha SY
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-025-04022-w
UR  - https://doi.org/10.1038/s41591-025-04022-w
ER  -

APA

YY, J., DY, O., M, P., ZA, W., S, P., S, N., A, D., A, T., DO, K., EAR, S., & SY, R. (2025). Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial.. Nature medicine. https://doi.org/10.1038/s41591-025-04022-w

Source records

pubmed · retrieved 2026-09-26T03:25:30.128Z
europe-pmc · retrieved 2026-09-26T03:25:30.127Z